Clinical Trial Update: Single Dose Enteral Tranexamic Acid in Critically Ill Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a single-dose enteral tranexamic acid in critically ill patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Hypotension
• Sepsis
• Shock

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: San Diego Veterans Healthcare System | Conditions: Shock, Sepsis | Phase 2 | Status: TERMINATED